Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 32, 2008, Pages 11358-11363

  Aharoni, Rina ^a   Herschkovitz, Avia ^a   Eilam, Raya ^a   Blumberg Hazan, Michal ^b   Sela, Michael ^a   Bruck, Wolfgang ^c   Arnon, Ruth ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b QuantomiX Ltd   (Israel)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Multiple sclerosis; Myelin repair; Neuroprotection; Oligodendrocyte

Indexed keywords

BROXURIDINE; CELL MARKER; GLATIRAMER;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MATURATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CLINICAL FEATURE; CONTROLLED STUDY; DEMYELINATION; DRUG MECHANISM; ELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; REMYELINIZATION; SCANNING ELECTRON MICROSCOPY; SPINAL CORD; STEM CELL;

ANIMALS; ANTIGENS; ANTIGENS, DIFFERENTIATION; AXONS; CELL PROLIFERATION; CHRONIC DISEASE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNOSUPPRESSIVE AGENTS; MICE; MICROSCOPY, ELECTRON, SCANNING; MULTIPLE SCLEROSIS; MYELIN SHEATH; OLIGODENDROGLIA; PEPTIDES; PROTEOGLYCANS; RECOVERY OF FUNCTION; SPINAL CORD; STEM CELLS;

ANIMALIA; MUS;

EID: 49649090657     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0804632105     Document Type: Article

References (20)

1. Lassmann H (1998) in: McAlpin's Multiple Sclerosis, eds Compston A, et al. (Churchill Livingstone, Oxford), pp 323-358.
2. Lassmann H (2007) Experimental models of multiple sclerosis. Rev Neurol 163:651-655.
3. Baumann N, Phan-Dinh D (2001) Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81:871-926.
4. Bruck W, Kuhlmann T, Stadelmann C (2003) Remyelination in multiple sclerosis. J Neurol Sci 206:181-185.
5. Reynolds R, et al. (2002) The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS. J Neurocytol 31:523-536.
6. Polito A, Reynolds R (2005) NG2-expressing cells as oligodendrocyte progenitors in the normal and demyelinated adult central nervous system. J Anat 207:707-716.
7. Arnon R, Sela M (2003) Immunomodulation by the copolymer glatiramer acetate.J Mol Recognit 16:412-421.
8. Aharoni R, Teitelbaum D, Sela M, Arnon R (1997) Copolymer 1 induces T cells of the T helper type 2 that cross-react with myelin basic protein and suppress experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 94:10821-10826.
9. Duda PW, et al. (2000) Glatiramer acetate (Copaxone) induces degenerate Th2-polarized immune responses in patients with multiple sclerosis. J Clin Invest 105:967-976.
10. Aharoni R, Kayhan B, Eilam R, Sela M, Arnon R (2003) Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ. Proc Natl Acad Sci USA 100:14157-14162.
11. Aharoni R, et al. (2005) The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice. Proc Natl Acad Sci USA 102:19045-19050.
12. Aharoni R, Eilam R, Arnon R (2005) Neurogenesis and neuroprotection induced by peripheral immunomodulatory treatment of experimental autoimmune encephalomyelitis. J Neurosci 25:8217-8228.
13. Gilgum-Sherki Y, Panet H, Holdengreber V, Mosberg-Galili R, Offen D (2003) Axonal damageis reduced following glatiramer acetate treatment in C57/bl mice with chronic-induced experimental autoimmune encephalomyelitis. Neurosci Res 47:201-207.
14. Maier K, et al. (2006) Effects of glatiramer acetate and interferon-β on neurodegeneration in a model of multiple sclerosis. Am J Pathol 169:1353-1364.
15. Nyska A, et al. (2006) A new method of wet scanning electron microscopy for analysis of myelination in EAE mouse model of multiple sclerosis. Exp Toxicol Pathol 57:291-297.
16. Feng G, et al. (2000) Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28:41-51.
17. Bjartmar C, Wujek JR, Trapp BD (2003) Axonal loss in the pathology of MS: Consequences for understanding the progressive phase of the disease. J Neurol Sci 15:165-171.
18. Kipnis J, et al. (2000) T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: Possible therapy for optic neuropathies. Proc Natl Acad Sci USA 97:7446-7451.
19. Franklin RJM, Hinks GL (1999) Understanding CNS remyelination: Clues from developmental and regeneration biology. J Neurosci Res 58:207-213.
20. Lalive PH, et al. (2005) TGF-beta-treated microglia induce oligodendrocyte precursor cell chemotaxis through the HGF-c-Met pathway. Eur J Immunol 35:727-737.